Crossmark

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

Crossref DOI link: https://doi.org/10.1007/s40268-018-0241-0

Published Online: 2018-07-27

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dimelow, Richard

Wright, James G.

MacPherson, Merran

Newell, Paul

Das, Shampa https://orcid.org/0000-0002-2540-4816
Funding

Funding for this research was provided by:

AstraZeneca

Pfizer
License Information

Text and Data Mining valid from 2018-07-27
More Information

Article History

First Online: 27 July 2018

Compliance with Ethical Standards

:

: Paul Newell and Shampa Das were employees of and shareholders in AstraZeneca at the time of this analysis. James G Wright is an employee of and shareholder in Wright Dose. Richard Dimelow and Merran MacPherson are former employees of Wright Dose. Merran MacPherson also holds shares in AstraZeneca. Wright Dose received funding from AstraZeneca for support and assistance with the population PK analysis.